• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Vaccine . Effect of lymphocyte miRNA expression on influenza vaccine-induced immunity

tetano

Editor, Senior Moderator
Vaccine


. 2025 Mar 23:55:127023.
doi: 10.1016/j.vaccine.2025.127023. Online ahead of print. Effect of lymphocyte miRNA expression on influenza vaccine-induced immunity

Iana H Haralambieva[SUP] 1 [/SUP], Tamar Ratishvili[SUP] 1 [/SUP], Krista M Goergen[SUP] 2 [/SUP], Diane E Grill[SUP] 2 [/SUP], Whitney L Simon[SUP] 1 [/SUP], Jun Chen[SUP] 2 [/SUP], Inna G Ovsyannikova[SUP] 1 [/SUP], Gregory A Poland[SUP] 1 [/SUP], Richard B Kennedy[SUP] 3 [/SUP]



Affiliations
Abstract

Alterations of gene expression by miRNAs contribute substantially to genetic regulation and cellular functions. We conducted a comprehensive study in 53 individuals before and after seasonal inactivated influenza vaccine to characterize lymphocyte-specific miRNA expression (in purified B cells, CD4+ T cells, CD8+ T cells, and NK cells) and its effect on influenza vaccine-induced immune outcomes (hemagglutination inhibition antibody titers/HAI, viral neutralizing antibody titers /VNA, and memory B cell ELISPOT). Overall, we observed relatively stable miRNA expression before and after influenza vaccination. Statistical analysis uncovered three baseline miRNAs (miR-150-3p, miR-629-5p, and miR-4443) that were significantly correlated with influenza vaccine-induced immune outcomes in different cell types. Predictive modeling of influenza vaccine-induced HAI/VNA titers identified a set of specific baseline miRNAs in CD4[SUP]+[/SUP] T cells as factors predictive of antibody responses. A pathway enrichment analysis on the putative target genes revealed several regulated signaling pathways and functions: TGF-β signaling, PI3K-Akt signaling, p53 signaling, MAPK signaling, TNF signaling, and C-type lectin receptor signaling, as well as cell adhesion and adherens junctions, and antiviral host response. In conclusion, our study offers evidence for the role of epigenetic modification (miRNAs) on influenza vaccine-induced immunity. After validation, identified miRNAs may serve as potential biomarkers of immune response after influenza vaccination.

Keywords: B cells; Immunity; Influenza vaccine; MicroRNA expression; NK cells; T cells.

 
Back
Top